Table 3.
Evaluation of the 17-gene Expression Signature Using Whole Gene Expression Data and Principal Components.
| Model | AIC | C-index |
|---|---|---|
| 17 genes | 2290 | 60.0 |
| PC1 | 2307 | 54.2 |
| PC1 + PC2 | 2284 | 60.9 |
| PC1 + PC2 + PC3 | 2279 | 60.7 |
| PC1 + PC2 + PC3 + PC4 | 2275 | 61.7 |
| PC1 + PC2 + PC3 + PC4 + PC5 | 2277 | 61.5 |
Bootstrapped c-indexes and Akaike information criteria are provided. Results were obtained from the whole cohort of DLBCL patients treated with R-CHOP (N = 481).
AIC = Akaike information criterion; c-index = concordance index; DLBCL = diffuse large B-cell lymphoma; PC = principal component; R-CHOP = rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.